The trading price of Apogee Therapeutics Inc (NASDAQ:APGE) floating lower at last check on current market day and closing at $39.44, -16.90% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $38.0725 and $47.355. In examining the 52-week price action we see that the stock hit a 52-week high of $63.50 and a 52-week low of $26.20. Over the past month, the stock has gained 8.05% in value.
Apogee Therapeutics Inc, whose market valuation is $2.35 billion at the time of this writing, is expected to release its quarterly earnings report on 2025-May-12. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -1.03 per share this quarter, however they have predicted annual earnings per share of -4.3 for current year and -4.86 for next year.
On the technical side, indicators suggest APGE has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently Hold.
A quick review shows that APGE’s price is currently -7.56% off the SMA20 and -1.52% off the SMA50. The RSI metric on the 14-day chart is currently showing 44.21, and weekly volatility stands at 5.88%. When measured over the past 30 days, the indicator reaches 6.09%. Apogee Therapeutics Inc (NASDAQ:APGE)’s beta value is currently sitting at 1.48. With analysts defining $95-$95 as the low and high price targets, we arrive at a consensus price target of $95 for the trailing 12-month period. The current price is about -140.87% off the estimated low and -140.87% off the forecast high, based on this estimate. Investors will be thrilled if APGE’s share price rises to $95, which is the median consensus price. At that level, APGE’s share price would be -140.87% below current price.
To see how Apogee Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: APGE stock’s performance was -16.90% at last check in today’s session, and -12.94% in the past year.
An evaluation of the daily trading volume of Apogee Therapeutics Inc (NASDAQ:APGE) indicates that the 3-month average is 746.57K. However, this figure has increased over the past 10 days to an average of 0.86.
Currently, records show that 46.04 million of the company’s shares remain outstanding. The insiders hold 37.32% of outstanding shares, whereas institutions hold 88.24%. The stats also highlight that short interest as of 2025-06-13, stood at 9.18 million shares, resulting in a short ratio of 12.41 at that time. From this, we can conclude that short interest is 3350.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were down slightly from the previous month’s figure, which was 10.21 million. However, since the stock’s price has seen 3.22% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
